These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 33431149

  • 1. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ.
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [Abstract] [Full Text] [Related]

  • 2. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
    de Boer PT, Backer JA, van Hoek AJ, Wallinga J.
    BMC Med; 2020 Jan 14; 18(1):11. PubMed ID: 31931789
    [Abstract] [Full Text] [Related]

  • 3. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L, Heikkinen T, Sackeyfio A, Pitman R.
    Pharmacoeconomics; 2016 Sep 14; 34(9):939-51. PubMed ID: 27423657
    [Abstract] [Full Text] [Related]

  • 4. Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
    Zeevat F, Crépey P, Dolk FCK, Postma AJ, Breeveld-Dwarkasing VNA, Postma MJ.
    Value Health; 2021 Jan 14; 24(1):3-10. PubMed ID: 33431150
    [Abstract] [Full Text] [Related]

  • 5. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM, Weidemann F, Damm O, Ultsch B, Greiner W, Wichmann O.
    Value Health; 2021 Jan 14; 24(1):32-40. PubMed ID: 33431151
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ, Stevenson MD, Smith MJ, LaJoie AS, Cross K.
    JAMA Pediatr; 2018 Jan 02; 172(1):e173879. PubMed ID: 29114729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT.
    BMC Infect Dis; 2015 Oct 27; 15():465. PubMed ID: 26503131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L, Roiz J, Faivre P, Reygrobellet C.
    Clin Drug Investig; 2012 Feb 01; 32(2):73-85. PubMed ID: 22201294
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):533-542. PubMed ID: 27780425
    [Abstract] [Full Text] [Related]

  • 13. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK, van Boven M, de Vries R, Postma MJ, Wallinga J.
    BMJ; 2012 Jul 12; 345():e4445. PubMed ID: 22791791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
    Sandmann FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, Castilla J, Domegan L, Gherasim A, Hooiveld M, Kislaya I, Larrauri A, Levy-Bruhl D, Machado A, Marques DFP, Martínez-Baz I, Mazagatos C, McMenamin J, Meijer A, Murray JLK, Nunes B, O'Donnell J, Reynolds A, Thorrington D, Pebody R, Baguelin M.
    Vaccine; 2022 Feb 23; 40(9):1306-1315. PubMed ID: 35109968
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M.
    BMC Med; 2017 Sep 08; 15(1):166. PubMed ID: 28882149
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
    Clements KM, Chancellor J, Nichol K, DeLong K, Thompson D.
    Value Health; 2011 Sep 08; 14(6):800-11. PubMed ID: 21914499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.